leadf
logo-loader
viewEmpower Clinics Inc.

Empower Clinics joins fight against coronavirus pandemic with four-phase US rollout of antibody testing

The health and wellness group has established a four-phase national testing program using RAPID COVID-19 test kits

Empower Clinics Inc. -
The test kits used are approved in the USA under the Emergency Use Authorization (EUA), as defined by the Food and Drug Administration

Empower Clinics Inc (CSE:CBDT) (OTCMKTS:EPWCF) is helping in the fight against the global pandemic and revealed it has started coronavirus (COVID-19) antibody testing at its Sun Valley Health clinics in Phoenix, Arizona, USA.

The health and wellness group has established a four-phase national testing program using RAPID COVID-19 test kits, it said in a statement on Monday.

Antibody testing is an essential part of the battle against the disease because it can help to establish who, and how many people, have been infected.

READ: Empower Clinics launches psilocybin research and psychedelic treatment subsidiary 

Phase One of Empower's program sees blood draw testing at its clinics in Arizona, using clinic phlebotomists. Samples are sent to Empower's laboratory test partner for analysis, with results expected within 48 hours.

Phase Two offers a Rapid COVID-19 antibody test with results in 1-15 minutes. The service will be offered in-clinics using a drive-up service, conducted by the firm's clinic staff, as well as a door-step service, using certified mobile technicians. Empower expects phase two services will begin in May this year.

Phase Three are so-called Business Employee Testing (BET) programs, also expected to kick off in May. These offer Rapid COVID-19 testing to businesses on a one-time basis, repeat basis and/or subscription basis, to assist businesses to get back to work safely.

Phase Four is a US nationwide roll-out, offering all phases of the company services, that can be accessed online at Empower websites and call centers, to purchase Rapid COVID-19 test kits. The company anticipates Phase Four services to start in the third quarter of this year.

"Our team are ready to meet the crisis head-on, and we have ensured that the test processes and the test kits we use, are approved in the United States under the Emergency Use Authorization (EUA), as defined by the U.S. Food and Drug Administration (FDA)," Steven McAuley, the chairman and CEO at Empower said in the statement.

Empower has secured test kit supply agreements with two suppliers - NanoID Technologies Pty Ltd and Emunah Trust, LLC.

Contact the author at giles@proactiveinvestors.com

Quick facts: Empower Clinics Inc.

Price: 0.035 CAD

CSE:CBDT
Market: CSE
Market Cap: $6.17 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Empower Clinics Inc. named herein, including the promotion by the Company of Empower Clinics Inc. in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Empower Clinics expands their COVID-19 testing programs by beginning PCR Testing

Empower Clinics (CSE: CBDT-OTCQB: EPWCF) Chairman and CEO Steven McAuley joined Steve Darling from Proactive Vancouver to share news the company has commenced COVID-19 PCR testing through its Sun Valley Health operations in Arizona. McAuley talks about the ramp-up of testing they are doing...

1 week, 1 day ago

2 min read